CD8A and neoplasm: To confirm the roles of CD8+ T cells and CXCL10 in the antitumor immune response following triple therapy administration, we depleted this population or cytokine in vivo and analyzed the effects on transplanted tumor growth and survival in the subcutaneous transplanted tumor model (figure 6A).